Abstract:Objective To explore the expression,correlation and clinical significance of mammalian target of rapamycin (mTOR) and vascular endothelial growth factor (VEGF) in gastroenteropancreatic neuroendocrine neoplasm (GEP-NEN).Methods From October 1995 to December 2012,the paraffin tissue specimens of 114 pathological diagnosed GEP-NEN were collected.The expressions of mTOR and VEGF at protein level were detected with EnVision immunohistochemical staining method.Chi-square test was performed to compare the differences in the expressions of mTOR and VEGF among every clinicopathological factors of patients.Spearman's correlation analysis was used to find out the correlation between the expressions of mTOR and VEGF.Kaplan Meier method and Log-rank test were implemented for survival analysis.Results The overall positive expression rates of mTOR and VEGF in GEP-NEN tissues were 66.7％ (76/114) and 71.1％ (81/114),respectively.The expressions ofmTORand VEGF at protein level were not correlated with gender,age,functional status of tumor,location of tumor,grading and classification of tumor and distant metastasis (all P＞0.05).The co-expression rate of mTOR and VEGF in GEP-NEN tissues was 51.8％ (59/114).The expression of mTOR was positively correlated with the expression of VEGF at protein level (r=0.205,P=0.029).Among 82 followed-up patients,the mean survival time of patients with mTOR positive or negative expression was 8.3 and 7.9 years,and respectively,and there was no statistical significance (x2 =0.201,P=0.654).The mean survival time of patients with VEGF positive or negative expression was 9.6 and 5.9 years,respectively,and the difference was statistically significant (x2 =4.415,P=0.036).Among the patients with G1 grading tumor,classified as neuroendocrine tumor and without distant metastasis,the survival time of patients with positive VEGF expression was longer than that of patients with negative VEGF expression (11.8 years vs 7.3 years,x2 =5.349,P=0.021; 11.2 years vs 6.8 years,x2=6.375,P=0.012; 11.2 years vs 7.2 years,x2 =4.630,P=0.031).Conclusions mTOR and VEGF proteins are highly expressed in GEP-NEN with different location,grading and classification.The expression of them is positively correlated.The prognosis of GEP-NEN patients with positive VEGF expression is better.

Expression of Mtor Signaling Pathway Proteins in Gliomas and Its Clinical Significance

Association between AKT/mTOR signalling pathway and malignancy grade of human gliomas

Mammalian Target Of Rapamycin Signaling Pathway Contributes To Glioma Progression And Patients' Prognosis

Roles of mTOR and p-mTOR in gastrointestinal stromal tumors.

Expression and clinical significance of mTOR/P70S6K signaling pathway in children glioma

Relationship between expressions of mammalian target of rapamycin and vascular endothelial growth factor and pathological grading of meningiomas

Expression and clinical significance of mTOR signaling pathway- associated proteins in pancreatic cancer

Expressions and Clinical Significance of MDM2, P53 and P21waf1 Proteins in Gliomas Tissues

Expressions of MMP2, TIMP2, Ki-67 and P53 in glioma tissues and their significance

Expression of Phosphorylated Mammalian Target of Rapamycin in Colorectal Cancer and Its Significance

Association of the Activation of the Mtor Pathway with Prognosis in Chinese Melanoma Patients.

The Expression and Clinical Significance of Mtor/p70s6k Signaling Pathway in Cervical Cancer

The Analysis on the Relationship Between Expressions of ABCG2, VEGF, IGFBP-2 and EGFR in Glioma Tissue Microarray and Prognosis

Role of Mtor Signaling Pathway in Glioma-Associated Seizures

Expression and Its Clinical Significance of Mammalian Target of Rapamycin and Vascular Endothelial Growth Factor in Gastroenteropancreatic Neuroendocrine Neoplasm

Activation of the Mammalian Target of Rapamycin Signalling Pathway in Prostate Cancer and Its Association with Patient Clinicopathological Characteristics

Expression of activated mTOR in gallbladder carcinoma tissue and its clinical significance

Clinical Significance of Aberrant Mammalian Target of Rapamycin Expression in Stage IIIB Colon Cancer

Clinical significance of aberrant mammalian target of rapamycin expression in stage IIIB colon cancer.

The expression of p-mammalian target of rapamycin in non-small cell lung cancer and its prognostic significance

Activation of mammalian target of rapamycin pathway confers adverse outcome in nonsmall cell lung carcinoma.